Transforming “cold” tumors into “hot” ones via tumor-microenvironment-responsive siRNA micelleplexes for enhanced immunotherapy

Folkman, 1971, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med., 285, 1182, 10.1056/NEJM197111182852108 Kuczynski, 2019, Vessel co-option in cancer, Nat. Rev. Clin. Oncol., 16, 469, 10.1038/s41571-019-0181-9 Jain, 2013, Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers, J. Clin. Oncol., 31, 2205, 10.1200/JCO.2012.46.3653 Carmeliet, 2011, Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases, Nat. Rev. Drug Discov., 10, 417, 10.1038/nrd3455 Jain, 2005, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, 307, 58, 10.1126/science.1104819 Sun, 2021, Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy, Sci. Transl. Med., 13, eabc8922, 10.1126/scitranslmed.abc8922 Barsoum, 2014, A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells, Cancer Res., 74, 665, 10.1158/0008-5472.CAN-13-0992 Jain, 2014, Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia, Cancer Cell, 26, 605, 10.1016/j.ccell.2014.10.006 Mpekris, 2020, Normalizing the microenvironment overcomes vessel compression and resistance to nano-immunotherapy in breast cancer lung metastasis, Adv. Sci., 8, 2001917, 10.1002/advs.202001917 Huang, 2018, Improving immune-vascular crosstalk for cancer immunotherapy, Nat. Rev. Immunol., 18, 195, 10.1038/nri.2017.145 Kabir, 2021, Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity, Sci. Transl. Med., 13, eabb6731, 10.1126/scitranslmed.abb6731 Liu, 2019, Tumor vasculatures: a new target for cancer immunotherapy, Trends Pharmacol. Sci., 40, 613, 10.1016/j.tips.2019.07.001 Potente, 2011, Basic and therapeutic aspects of angiogenesis, Cell, 146, 873, 10.1016/j.cell.2011.08.039 Shigeta, 2020, Dual programmed death receptor-1 and vascular endothelial growth factor receptor-2 blockade promotes vascular normalization and enhances antitumor immune responses in hepatocellular carcinoma, Hepatology, 71, 1247, 10.1002/hep.30889 Schmittnaegel, 2017, Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade, Sci. Transl. Med., 9, eaak9670, 10.1126/scitranslmed.aak9670 Chen, 2017, Elements of cancer immunity and the cancer–immune set point, Nature, 541, 321, 10.1038/nature21349 Nam, 2019, Cancer nanomedicine for combination cancer immunotherapy, Nat. Rev. Mater., 4, 398, 10.1038/s41578-019-0108-1 Galon, 2019, Approaches to treat immune hot, altered and cold tumours with combination immunotherapies, Nat. Rev. Drug Discov., 18, 197, 10.1038/s41573-018-0007-y Martin, 2020, Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges, Nat. Rev. Clin. Oncol., 17, 251, 10.1038/s41571-019-0308-z Krysko, 2012, Immunogenic cell death and DAMPs in cancer therapy, Nat. Rev. Cancer, 12, 860, 10.1038/nrc3380 Kono, 2008, How dying cells alert the immune system to danger, Nat. Rev. Immunol., 8, 279, 10.1038/nri2215 Galluzzi, 2017, Immunogenic cell death in cancer and infectious disease, Nat. Rev. Immunol., 17, 97, 10.1038/nri.2016.107 Duan, 2019, Nanoparticle-mediated immunogenic cell death enables and potentiates cancer immunotherapy, Angew. Chem. Int. Ed., 58, 670, 10.1002/anie.201804882 Zhu, 2020, Tumor-exocytosed exosome/aggregation-induced emission luminogen hybrid nanovesicles facilitate efficient tumor penetration and photodynamic therapy, Angew. Chem. Int. Ed., 59, 13836, 10.1002/anie.202003672 Chen, 2018, Bioinspired hybrid protein oxygen nanocarrier amplified photodynamic therapy for eliciting anti-tumor immunity and abscopal effect, ACS Nano, 12, 8633, 10.1021/acsnano.8b04371 Li, 2019, Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death, Nat. Commun., 10, 3349, 10.1038/s41467-019-11269-8 Gao, 2017, Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy, Biomaterials, 112, 324, 10.1016/j.biomaterials.2016.10.030 Zeng, 2020, Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy, Chem. Eng. J., 389, 124494, 10.1016/j.cej.2020.124494 Zhang, 2019, SnTe@MnO2-SP nanosheet-based intelligent nanoplatform for second near-infrared light-mediated cancer theranostics, Adv. Funct. Mater., 29, 1903791, 10.1002/adfm.201903791 Zhou, 2019, Tumor microenvironment-activatable prodrug vesicles for nanoenabled cancer chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade, Adv. Mater., 31, 1805888, 10.1002/adma.201805888 Sun, 2021, Regulating glucose metabolism with prodrug nanoparticles for promoting photoimmunotherapy of pancreatic cancer, Adv. Sci., 8, 2002746, 10.1002/advs.202002746 Jeong, 2018, Peptide-nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?, Nano Converg, 5, 38, 10.1186/s40580-018-0170-1 Taleb, 2021, Bifunctional therapeutic peptide assembled nanoparticles exerting improved activities of tumor vessel normalization and immune checkpoint inhibition, Adv. Healthc. Mater., 10, 2100051, 10.1002/adhm.202100051 Zou, 2016, Current approaches of photothermal therapy in treating cancer metastasis with nanotherapeutics, Theranostics, 6, 762, 10.7150/thno.14988 Schroeder, 2012, Treating metastatic cancer with nanotechnology, Nat. Rev. Cancer, 12, 39, 10.1038/nrc3180 Tian, 2017, Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming, Nature, 544, 250, 10.1038/nature21724 Song, 2016, Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated macrophages toward M1-like phenotype and attenuating tumor hypoxia, ACS Nano, 10, 633, 10.1021/acsnano.5b06779 DeNardo, 2019, Macrophages as regulators of tumour immunity and immunotherapy, Nat. Rev. Immunol., 19, 369, 10.1038/s41577-019-0127-6 Zhang, 2019, Cooperatively responsive peptide nanotherapeutic that regulates angiopoietin receptor Tie2 activity in tumor microenvironment to prevent breast tumor relapse after chemotherapy, ACS Nano, 13, 5091, 10.1021/acsnano.8b08142 Li, 2020, Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy, Sci. Adv., 6, eaaz9240, 10.1126/sciadv.aaz9240